Sangamo Therapeutics Inc (NASDAQ:SGMO) - Share price - Overview

Stock Report

Sangamo Therapeutics Inc SGMO

Last Price
$16.35

Day Change
-0.05|-0.30%

As of 15/12/2017
16:14:05 EST | USD
Minimum 15 Minutes Delay.

Last Close16.40
Day Range16.00 - 16.70
Mkt Cap1.39Bil
52-Wk Range2.85 - 18.40
Yield %-
ISINUS8006771062
Volume2,640,207
P/E-23.70
P/S37.74
P/CF75.00

Share Price

Financials
201420152016
More ...
Income Statement
Revenue45.8739.5419.39
Operating Income-26.78-46.86-72.56
Net Income-26.42-40.70-71.66
Basic EPS-0.39-0.58-1.02
Avg. Diluted Shares Outstanding677071
Balance Sheet
Current Assets190.88212.58149.58
Non Current Assets52.334.658.31
Total Assets243.21217.24157.89
Current Liabilities20.8820.1013.29
Total Liabilities36.5824.8021.70
Total Equity206.63192.44136.20
Cash Flow
Operating Cash Flow-5.68-33.72-65.88
Capital Expenditure-0.62-2.41-0.73
Free Cash Flow-6.30-36.13-66.62

In millions, except "Basic EPS". Currency is USD.

Company Profile

Sangamo Therapeutics Inc is a clinical stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Blend

Fiscal Year Ends

December

Employees

131
Key Stats
More ...
Price/Earning TTM-23.77
Price/Book7.43
Price/Sales TTM37.72
Rev Growth (3 year avg)-7.04
EPS Growth (3 year avg)-
Operating Margin % TTM-374.23
Net Margin % TTM-369.58
ROE TTM-43.61
Debt/Equity0.03
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.